A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Biperiden
Abatacept
The risk or severity of adverse effects can be increased when Estramustine is combined with Abatacept.
Biperiden
Busulfan
The risk or severity of adverse effects can be increased when Busulfan is combined with Estramustine.
Biperiden
Dasatinib
The risk or severity of adverse effects can be increased when Estramustine is combined with Dasatinib.
Biperiden
Budesonide
The risk or severity of adverse effects can be increased when Estramustine is combined with Budesonide.
Biperiden
Bleselumab
The risk or severity of adverse effects can be increased when Estramustine is combined with Bleselumab.
Biperiden
Rozanolixizumab
The risk or severity of adverse effects can be increased when Estramustine is combined with Rozanolixizumab.
Biperiden
Risankizumab
The risk or severity of adverse effects can be increased when Estramustine is combined with Risankizumab.
Biperiden
Hydrocortisone succinate
The risk or severity of adverse effects can be increased when Estramustine is combined with Hydrocortisone succinate.
Biperiden
Hydrocortisone acetate
The risk or severity of adverse effects can be increased when Estramustine is combined with Hydrocortisone acetate.
Biperiden
Mometasone furoate
The risk or severity of adverse effects can be increased when Estramustine is combined with Mometasone furoate.
Biperiden
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Estramustine is combined with Monomethyl fumarate.
Biperiden
Tetrandrine
The risk or severity of adverse effects can be increased when Estramustine is combined with Tetrandrine.
Biperiden
Fluticasone
The risk or severity of adverse effects can be increased when Estramustine is combined with Fluticasone.
Biperiden
Fluclorolone
The risk or severity of adverse effects can be increased when Estramustine is combined with Fluclorolone.
Biperiden
Cloprednol
The risk or severity of adverse effects can be increased when Estramustine is combined with Cloprednol.
Biperiden
Fluperolone
The risk or severity of adverse effects can be increased when Estramustine is combined with Fluperolone.
Biperiden
Begelomab
The risk or severity of adverse effects can be increased when Estramustine is combined with Begelomab.
Biperiden
Fluocortin
The risk or severity of adverse effects can be increased when Estramustine is combined with Fluocortin.
Biperiden
Prednylidene
The risk or severity of adverse effects can be increased when Estramustine is combined with Prednylidene.
Biperiden
9-(N-methyl-L-isoleucine)-cyclosporin A
The risk or severity of adverse effects can be increased when Estramustine is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3